Associated Papers
DEL variants: review of molecular mechanisms, clinical consequences and molecular testing strategy.
Yin Q
Functional & Integrative Genomics, 2023
Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia.
Genovese G et al.
Nature Neuroscience, 2016
27694994 (PubMed )
Supplement: NIHMS815183-supplement-supp_table3.xlsx › Supplemenary_Table_3
Comprehensive analysis of RHD splicing transcripts reveals the molecular basis for the weak anti-D reactivity of Del -red blood cells.
Chen DP et al.
Transfusion Medicine (oxford, England), 2016
Weak D alleles in Japanese: a c.960G>A silent mutation in exon 7 of the RHD gene that affects D expression.
Ogasawara K et al.
Vox Sanguinis, 2016
Clinical and laboratory update on the DEL variant.
Nuchnoi P et al.
Laboratory Medicine, 2014
Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations.
Flegel WA et al.
Transfusion, 2009
Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study.
Gassner C et al.
Transfusion, 2005
Select a paper to view details